1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3307)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (236)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11741)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Pathogenic germline mutations in a large cohort of multiple myeloma
    Meeting Abstract

    Conry, M.; Camp, N.; Vachon, C.; Slager, S.; Hildebrandt, M.; Brown, E.; Garber, J.; Norman, A.; Stokes, S.; Lipkin, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • New treatment modality for pancreatic cancer-Vascular Targeted Photodynamic therapy with WST11 (Padeliporfin) combined with endovascular light delivery
    Meeting Abstract

    Agemy, L.; Sasson, K.; Yechezkel, T.; Priese, D.; Cohen, Y.; Zacks, Z.; Stelzer, G.; Kelsen, D. P.; Yarmohammadi, H.; Wei, A. C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • CT radiomics to predict early recurrence of margin-negative resectable pancreatic ductal adenocarcinoma
    Meeting Abstract

    Dhara, A.; Langdon-Embry, L.; D'Angelica, M. I.; Kingham, T. P.; Horvat, N.; Jarnagin, W. R.; Wei, A. C.; Chakraborty, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study
    Meeting Abstract

    Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Association of linguistic barriers and survival in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Walji, M.; Lee, J.; Devlin, S. M.; Gany, F.; Perales, M. A.; Giralt, S. A.; Cho, C.
    Blood (2022)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 primo trial expansion phase: Impact of prior treatment and expanded safety analysis
    Meeting Abstract

    Jacobsen, E. D.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter-Brown, L. C.; Izutsu, K.; Daugherty, M.; Brammer, J. E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tub-010, a novel antibody-drug-conjugate with reduced nonspecific toxicity profile based on tub-tag technology widens the therapeutic window for the treatment of CD30+malignancies
    Meeting Abstract

    Gerlach, M.; Schmitt, S.; Cyprys, P.; Kasper, M. A.; Mai, I.; Vermeer, M. H.; Horwitz, S. M.; Fingerle-Rowson, G. R.; Vogl, A.; Schumacher, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation
    Meeting Abstract

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
    Blood (2022)

    Fulltext@MSK | Save